{
    "body": "Is muscle lim protein (MLP) involved in cardiomyopathies?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/16228909", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22421737", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15978612", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15639480", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11788418", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21562304", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21484537", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15205937", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18083727", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22371524", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14567970", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16352453", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12642359", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18505755", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12397030", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17535853", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24860983"
    ], 
    "ideal_answer": [
        "The skeletal muscle LIM protein 1 (SLIM1) is highly expressed in skeletal and cardiac muscle, and its expression is downregulated significantly in dilated human cardiomyopathy. Loss of murine MLP results in dilated cardiomyopathy, and mutations in human MLP lead to cardiac hypertrophy, indicating a critical role for MLP in maintaining normal cardiac function.", 
        "Yes, Muscle LIM protein is involved in cardiomyopathies. In specific, the skeletal muscle LIM protein 1 (SLIM1) is highly expressed in skeletal and cardiac muscle, and its expression is downregulated significantly in dilated human cardiomyopathy. Mutations in the human MLP gene are associated with hypertrophic and dilated cardiomyopathy. MLP became an important model for experimental cardiology when it was first demonstrated that MLP deficiency leads to myocardial hypertrophy followed by a dilated cardiomyopathy and heart failure phenotype."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009202", 
        "http://www.disease-ontology.org/api/metadata/DOID:0050700"
    ], 
    "type": "yesno", 
    "id": "54f704b630767eb92e000001", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 339, 
            "text": "Muscle LIM protein (MLP) has been proposed to be a central player in the pathogenesis of heart muscle disease. In line with this notion, the homozygous loss of MLP results in cardiac hypertrophy and dilated cardiomyopathy. Moreover, MLP is induced in several models of cardiac hypertrophy such as aortic banding and myocardial infarction. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421737", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 6, 
            "offsetInEndSection": 100, 
            "text": "Muscle LIM protein (MLP) null mice are often used as a model for human dilated cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22371524", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1710, 
            "offsetInEndSection": 1858, 
            "text": "A lack of MLP leads to an age-dependent impairment of excitation-contraction coupling with resulting contractile dysfunction and secondary fibrosis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22371524", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 133, 
            "offsetInEndSection": 317, 
            "text": "Loss of murine MLP results in dilated cardiomyopathy, and mutations in human MLP lead to cardiac hypertrophy, indicating a critical role for MLP in maintaining normal cardiac function.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21562304", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1276, 
            "offsetInEndSection": 1390, 
            "text": "Our data indicate that MLP contributes to muscle stiffness and is necessary for maximum work and power generation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21562304", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 616, 
            "offsetInEndSection": 1110, 
            "text": "Interestingly, MLP was also found to be down-regulated in humans with heart failure (Zolk et al. Circulation 101:2674-2677, 2000) and MLP mutations are able to cause hypertrophic and dilated forms of cardiomyopathy in humans (Bos et al. Mol Genet Metab 88:78-85, 2006; Geier et al. Circulation 107:1390-1395, 2003; Hershberger et al. Clin Transl Sci 1:21-26, 2008; Kn\u00f6ll et al. Cell 111:943-955, 2002; Kn\u00f6ll et al. Circ Res 106:695-704, 2010; Mohapatra et al. Mol Genet Metab 80:207-215, 2003).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21484537", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 264, 
            "offsetInEndSection": 513, 
            "text": "MLP soon became an important model for experimental cardiology when it was first demonstrated that MLP deficiency leads to myocardial hypertrophy followed by a dilated cardiomyopathy and heart failure phenotype (Arber et al. Cell 88:393-403, 1997). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21484537", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 218, 
            "offsetInEndSection": 459, 
            "text": "Previous studies have shown an association between CSRP3 missense mutations and either dilated cardiomyopathy (DCM) or HCM, but all these studies were unable to provide comprehensive genetic evidence for a causative role of CSRP3 mutations. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18505755", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 709, 
            "offsetInEndSection": 1124, 
            "text": "We used a newly designed monoclonal antibody to show that muscle LIM protein (MLP), the protein encoded by CSRP3, is mainly a cytosolic component of cardiomyocytes and not tightly anchored to sarcomeric structures. Our functional data from both in vitro and in vivo analyses suggest that at least one of MLP's mutated forms seems to be destabilized in the heart of HCM patients harbouring a CSRP3 missense mutation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18505755", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Muscle LIM protein (MLP) is a cytoskeletal protein located at the Z-disc of sarcomeres. Mutations in the human MLP gene are associated with hypertrophic and dilated cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18083727", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 923, 
            "offsetInEndSection": 1156, 
            "text": "Our data demonstrate that Mlp84B is essential for normal cardiac function and establish the Drosophila model for the investigation of the mechanisms connecting defective cardiac Z-disc components to the development of cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18083727", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 148, 
            "text": "Muscle LIM protein (MLP) is a cytoskeletal LIM-only protein expressed in striated muscle. Mutations in human MLP are associated with cardiomyopathy;", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17535853", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 370, 
            "text": "TTN-encoded titin, CSRP3-encoded muscle LIM protein, and TCAP-encoded telethonin are Z-disc proteins essential for the structural organization of the cardiac sarcomere and the cardiomyocyte's stretch sensor. All three genes have been established as cardiomyopathy-associated genes for both dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16352453", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1548, 
            "offsetInEndSection": 1883, 
            "text": "Approximately 4.1% of unrelated patients had HCM-associated MLP or TCAP mutations. MLP/TCAP-HCM phenotypically mirrors myofilament-HCM and is more severe than the subset of patients who still remain without a disease-causing mutation. The precise role of W4R-MLP in the pathogenesis of either DCM or HCM warrants further investigation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16352453", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1274, 
            "offsetInEndSection": 1487, 
            "text": "MLP (muscle-LIM-protein) deficient mice develop DCM and changes in the mechanical coupling of cardiomyocytes result in alterations at the intercalated disks and enhanced accumulation of adherens junction proteins.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16228909", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 144, 
            "text": "Targeted deletion of cytoskeletal muscle LIM protein (MLP) in mice consistently leads to dilated cardiomyopathy (DCM) after one or more months. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15978612", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1307, 
            "offsetInEndSection": 1660, 
            "text": "In summary, young MLPKO mice revealed substantial alterations in passive myocardial properties and relaxation time, but not in most systolic characteristics. These results indicate that the progression to heart failure in the MLPKO model may be driven by diastolic myocardial dysfunction and abnormal passive properties rather than systolic dysfunction.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15978612", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 139, 
            "offsetInEndSection": 280, 
            "text": "Mice lacking the muscle LIM protein (MLP) develop morphological and clinical signs resembling human dilated cardiomyopathy and heart failure.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15639480", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1375, 
            "offsetInEndSection": 1772, 
            "text": "Our results show that the absence of MLP causes a local loss of mitochondria. We hypothesize that this is caused by a disturbed interaction between cytoskeleton and mitochondria, which interferes with energy sensing and energy transfer. Recovery of energy depletion by stimulating mitochondrial biogenesis might be a useful therapeutic strategy for improving the energy imbalance in heart failure.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15639480", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 317, 
            "text": "Previous work has shown that mutations in muscle LIM protein (MLP) can cause hypertrophic cardiomyopathy (HCM). In order to gain an insight into the molecular basis of the disease phenotype, we analysed the binding characteristics of wild-type MLP and of the (C58G) mutant MLP that causes hypertrophic cardiomyopathy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15205937", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 915, 
            "offsetInEndSection": 1092, 
            "text": "The molecular basis for HCM-causing mutations in the MLP gene might therefore be an alteration in the equilibrium of interactions of the ternary complex MLP-N-RAP-alpha-actinin.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15205937", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 219, 
            "offsetInEndSection": 572, 
            "text": "Muscle LIM protein (MLP) is a member of the cysteine-rich protein (CRP) family and has been implicated in both myogenesis and sarcomere assembly. In the latter role, it binds zyxin and alpha-actinin, both of which are involved in actin organization. An MLP-deficient mouse has been described; these mice develop dilated cardiomyopathy and heart failure.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14567970", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 770, 
            "offsetInEndSection": 896, 
            "text": "We identified a patient with DCM and EFE, having a mutation in MLP with the residue lysine 69 substituted by arginine (K69R). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14567970", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 195, 
            "offsetInEndSection": 402, 
            "text": "MLP-knockout mice develop a marked cardiac hypertrophy reaction and dilated cardiomyopathy (DCM). MLP is therefore a candidate gene for heritable forms of hypertrophic cardiomyopathy (HCM) and DCM in humans.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12642359", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1166, 
            "offsetInEndSection": 1365, 
            "text": "Family studies revealed cosegregation of clinically affected individuals with the respective mutations in MLP. CONCLUSION: Here, we present evidence that mutations in the CRP3/MLP gene can cause HCM.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12642359", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 177, 
            "text": "The skeletal muscle LIM protein 1 (SLIM1) is highly expressed in skeletal and cardiac muscle, and its expression is downregulated significantly in dilated human cardiomyopathy. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12397030", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 141, 
            "offsetInEndSection": 412, 
            "text": "Targeted disruption of muscle LIM protein (MLP) has previously been shown to result in dilated cardiomyopathy with many of the clinical signs of heart failure, although the effects of MLP disruption on passive ventricular mechanics and myocyte architecture are not known.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11788418", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 915, 
            "offsetInEndSection": 1189, 
            "text": "These results suggest that the disruption of the cytoskeletal protein MLP results in less compliant passive tissue and concomitant structural alterations in the three-dimensional myocyte architecture that may in part explain the ventricular dysfunction in the dilated heart.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11788418", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 110, 
            "offsetInEndSection": 347, 
            "text": " Mutations in cysteine and glycine-rich protein 3 (CSRP3), the gene encoding MLP, have been directly associated with human cardiomyopathies, whereas aberrant expression patterns are reported in human cardiac and skeletal muscle diseases.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24860983", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 110, 
            "text": "Muscle LIM protein (MLP) has been proposed to be a central player in the pathogenesis of heart muscle disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22421737", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 110, 
            "text": "Previous work has shown that mutations in muscle LIM protein (MLP) can cause hypertrophic cardiomyopathy (HCM)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15205937", 
            "endSection": "abstract"
        }
    ]
}